NO944113L - Stabilt, hydratisert cefalosporin-tört pulver for oral suspensjonsformulering - Google Patents

Stabilt, hydratisert cefalosporin-tört pulver for oral suspensjonsformulering

Info

Publication number
NO944113L
NO944113L NO944113A NO944113A NO944113L NO 944113 L NO944113 L NO 944113L NO 944113 A NO944113 A NO 944113A NO 944113 A NO944113 A NO 944113A NO 944113 L NO944113 L NO 944113L
Authority
NO
Norway
Prior art keywords
pct
oral suspension
stable
dried powder
suspension formulation
Prior art date
Application number
NO944113A
Other languages
English (en)
Other versions
NO944113D0 (no
NO307594B1 (no
Inventor
Donald A Johnson
Lorraine Wearley
Rebecca Galeos
Joel August Sequeira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO944113D0 publication Critical patent/NO944113D0/no
Publication of NO944113L publication Critical patent/NO944113L/no
Publication of NO307594B1 publication Critical patent/NO307594B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
NO944113A 1992-04-30 1994-10-28 Fremgangsmåte for fremstilling av en tørr, hydratisert cefalosporinpulverformulering, og farmsøytisk preparat NO307594B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87688192A 1992-04-30 1992-04-30
PCT/US1993/003856 WO1993021923A1 (en) 1992-04-30 1993-04-30 Stable hydrated cephalosporin dry powder for oral suspension formulation

Publications (3)

Publication Number Publication Date
NO944113D0 NO944113D0 (no) 1994-10-28
NO944113L true NO944113L (no) 1994-10-28
NO307594B1 NO307594B1 (no) 2000-05-02

Family

ID=25368763

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944113A NO307594B1 (no) 1992-04-30 1994-10-28 Fremgangsmåte for fremstilling av en tørr, hydratisert cefalosporinpulverformulering, og farmsøytisk preparat

Country Status (22)

Country Link
US (1) US5599557A (no)
EP (1) EP0642344B1 (no)
JP (1) JP3378004B2 (no)
KR (1) KR100257803B1 (no)
AT (1) ATE150310T1 (no)
AU (1) AU674516B2 (no)
CA (1) CA2134467A1 (no)
CZ (1) CZ283428B6 (no)
DE (1) DE69309052T2 (no)
DK (1) DK0642344T3 (no)
EE (1) EE03039B1 (no)
ES (1) ES2099438T3 (no)
FI (1) FI945081A0 (no)
GR (1) GR3023516T3 (no)
HU (1) HU215958B (no)
NO (1) NO307594B1 (no)
NZ (1) NZ252433A (no)
PL (1) PL171630B1 (no)
RU (1) RU2123863C1 (no)
SK (1) SK279329B6 (no)
UA (1) UA27899C2 (no)
WO (1) WO1993021923A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
KR100342943B1 (ko) * 1999-08-04 2002-07-02 민경윤 비결정질 세푸록심 악세틸 고형분산체, 이의 제조 방법 및 이를 포함하는 경구투여용 조성물
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
EP1648418A4 (en) * 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2533292C (en) * 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1648415A4 (en) * 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
WO2005016311A1 (en) * 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
CA2535398C (en) * 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
EP1658034A4 (en) * 2003-08-29 2011-06-22 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
WO2005027877A1 (en) * 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004308419B2 (en) * 2003-12-24 2011-06-02 Victory Pharma, Inc. Enhanced absorption of modified release dosage forms
US8715727B2 (en) * 2004-07-02 2014-05-06 Shionogi Inc. Tablet for pulsed delivery
US8653145B2 (en) * 2005-09-22 2014-02-18 Eaton Scientific Systems, Ltd. Method for alleviating climacteric symptoms
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US20100048609A1 (en) * 2006-08-01 2010-02-25 Jacobs Jeffrey W Pharmaceutical dosage forms for (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
FR2911506B1 (fr) * 2007-01-18 2009-07-03 Ceva Sante Animale Sa Compositions pharmaceutiques destinees a une administration par voie orale sous forme de suspensions aqueuses stabilisees
US8999395B2 (en) 2007-02-09 2015-04-07 Ceva Sante Animale Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions
EP2172223B1 (en) * 2007-06-22 2020-12-16 Kaneka Corporation Composition containing physiologically active substance
US20110123505A1 (en) * 2007-08-22 2011-05-26 Kaneka Corporation Method of producing reduced coenzyme q10 and method of stabilizing the same
WO2011139253A2 (en) * 2010-05-04 2011-11-10 Mahmut Bilgic Pharmaceutical compositions comprising ceftibuten
RU2550932C1 (ru) * 2014-03-18 2015-05-20 Александр Александрович Кролевец Способ получения нанокапсул цефалоспориновых антибиотиков в ксантановой камеди
GB202306826D0 (en) 2023-05-09 2023-06-21 Adjutec Pharma As Therapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549746A (en) * 1967-11-02 1970-12-22 Bristol Myers Co Antibiotic composition
US3780195A (en) * 1969-10-22 1973-12-18 Balchem Corp Encapsulation process
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
IT1183574B (it) * 1985-05-08 1987-10-22 Eurand Spa Metodo per ottenere una sospensione estemporanea omogenea di microcapsule
NZ220764A (en) * 1986-07-02 1989-09-27 Shionogi & Co Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions
US4803082A (en) * 1987-10-28 1989-02-07 Warner-Lambert Company Flavor and sweetness enhancement delivery systems and method of preparation
US5112604A (en) * 1989-09-01 1992-05-12 Riker Laboratories, Inc. Oral suspension formulation

Also Published As

Publication number Publication date
AU674516B2 (en) 1997-01-02
DE69309052T2 (de) 1997-06-19
SK279329B6 (sk) 1998-10-07
HK1002407A1 (en) 1998-08-21
JPH07506366A (ja) 1995-07-13
JP3378004B2 (ja) 2003-02-17
NZ252433A (en) 1996-07-26
HU215958B (hu) 1999-03-29
KR950701224A (ko) 1995-03-23
HUT71226A (en) 1995-11-28
PL171630B1 (pl) 1997-05-30
CZ263694A3 (en) 1995-04-12
RU2123863C1 (ru) 1998-12-27
US5599557A (en) 1997-02-04
NO944113D0 (no) 1994-10-28
SK131194A3 (en) 1995-07-11
KR100257803B1 (en) 2000-08-01
NO307594B1 (no) 2000-05-02
FI945081L (fi) 1994-10-28
RU94046038A (ru) 1996-11-10
WO1993021923A1 (en) 1993-11-11
EP0642344A1 (en) 1995-03-15
AU4115293A (en) 1993-11-29
GR3023516T3 (en) 1997-08-29
CZ283428B6 (cs) 1998-04-15
EE03039B1 (et) 1997-10-15
HU9403108D0 (en) 1995-02-28
ES2099438T3 (es) 1997-05-16
UA27899C2 (uk) 2000-10-16
DE69309052D1 (de) 1997-04-24
FI945081A7 (fi) 1994-10-28
ATE150310T1 (de) 1997-04-15
EP0642344B1 (en) 1997-03-19
CA2134467A1 (en) 1993-11-11
DK0642344T3 (da) 1997-07-07
FI945081A0 (fi) 1994-10-28

Similar Documents

Publication Publication Date Title
NO944113D0 (no) Stabilt, hydratisert cefalosporin-tört pulver for oral suspensjonsformulering
BG103518A (en) 2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives
HUT37418A (en) Process for producing new 2,2'-imino-bis/ethanol/ derivatives and pharmaceutical compositions sontaining them as active agents
ES8608864A1 (es) Un procedimiento para producir un preparado a modo de hojas
MY101791A (en) New benzimidazole derivatives
DE3783356D1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
IL84944A (en) Pharmaceutical compositions containing 1,2-dihydro-3h-indazolone derivatives,some new such compounds and their preparation
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
MY115429A (en) Fenbendazole formulations
UA74388C2 (uk) Фармацевтичні композиції тизоксаніду і нітазоксаніду
ES8404852A1 (es) Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos
DE3474024D1 (en) Contraceptive compositions based on esters of levo-norgestrel
HUT54166A (en) Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient
SG181694G (en) Solid oral administration forms containing ifosfamide as active agent
HU9302813D0 (en) Pharmaceutical compositions containing new benzimidazole derivatives and process for preparing the active ingredients
PL308580A1 (en) Solid pharmaceutical composition for oral administration and method of preparing same
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
HUT61776A (en) Process for producing 3' and/or 4' oh-modificated elsamycin derivatives and pharmaceutical compositions containing them as active components
IL67400A0 (en) 3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
JO1653B1 (en) The current benzimidazole is a therapeutically active method for preparing it

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN OCTOBER 2001